Filing Details

Accession Number:
0001225208-10-013998
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-26 13:00:00
Reporting Period:
2010-05-24
Filing Date:
2010-05-26
Accepted Time:
2010-05-26 17:42:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
732485 Genzyme Corp GENZ Biological Products, (No Disgnostic Substances) (2836) 061047163
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021029 A Richard Moscicki 500 Kendall Street
Cambridge MA 02142
Sr Vp,Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Genzyme Common Stock (Genz) Acquisiton 2010-05-24 8,083 $0.00 23,561 No 4 M Direct
Genzyme Common Stock (Genz) Disposition 2010-05-25 2,731 $45.63 20,830 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Genzyme Common Stock (Genz) Restricted Stock Units Disposition 2010-05-24 8,083 $0.00 8,083 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-05-24 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Genzyme Common Stock (Genz) 218 Indirect By 401(k)
Footnotes
  1. Restricted stock unit shares automatically sold to cover withholding tax obligations.
  2. Each restricted stock unit represents a contingent right to receive one share of Genzyme common stock.
  3. The restricted stock units vest 100% on the 3rd anniversary of the date of grant.